2012 Annual Report - Hong Kong Monetary Authority
2012 Annual Report - Hong Kong Monetary Authority
2012 Annual Report - Hong Kong Monetary Authority
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANZ ANNUAL REPORT <strong>2012</strong><br />
1 The maximum value at the time of the grant is determined by multiplying the number<br />
granted by the fair value of the equity instruments. The minimum value of the grants, if<br />
the applicable conditions are not met at vesting date, is nil. Options/rights granted include<br />
those granted as remuneration to the five highest paid executives in the Company and<br />
the Group (being the five highest paid, relevant Group and Company executives who<br />
participate in making decisions that affect the whole, or a substantial part, of the business<br />
of the Company or who have the capacity to significantly affect the Company’s financial<br />
standing). No options/rights have been granted since the end of <strong>2012</strong> up to the signing of<br />
the Director’s <strong>Report</strong> on 5 November <strong>2012</strong>.<br />
2 The value of shares and/or share rights and/or performance rights is based on the one<br />
day VWAP of the Company’s shares traded on the ASX on the date of vesting, lapsing or<br />
exercising, multiplied by the number of shares and/or share rights and/or performance<br />
rights. The value of options is based on the difference between the one day VWAP and the<br />
exercise price, multiplied by the number of options.<br />
3 For KMP who ceased employment during <strong>2012</strong>, the number of equity instruments “Vested<br />
and exercisable” are as at their date of cessation.<br />
4 D Hisco – Hurdled options granted 5 November 2004 were exercised on 4 November 2011.<br />
One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. STI deferred<br />
share rights granted 12 November 2010 were exercised on 14 November 2011. One day<br />
VWAP on date of exercise was $20.8876.<br />
5 G Hodges – Hurdled options granted 5 November 2004 were exercised on 4 November<br />
2011. One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. LTI<br />
performance rights granted 31 October 2008 were exercised on 9 November 2011. One day<br />
VWAP on date of exercise was $21.8346.<br />
6 J Phillips – was appointed to the CEO Global Wealth & Private Banking role on 1 March <strong>2012</strong><br />
and no equity transactions were applicable for the period.<br />
7 A Thursby – LTI performance rights granted 31 October 2008 were exercised on 4 November<br />
2011. One day VWAP on date of exercise was $20.9933.<br />
8 N Williams – was appointed to the Chief Risk Officer role on 17 December 2011 and no<br />
equity transactions were applicable for the period.<br />
9 P Marriott – ceased employment 31 August <strong>2012</strong> so equity transactions are to that date.<br />
Transactions include those that transpired prior to cessation and those that were forfeited<br />
on cessation. Hurdled options granted 5 November 2004 were exercised on 4 November<br />
2011. One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. STI<br />
deferred options granted 31 October 2008 were exercised on 11 May <strong>2012</strong>. One day VWAP<br />
on date of exercise was $22.0692. The exercise price was $17.18. LTI performance rights<br />
granted 31 October 2008 were exercised on 10 November 2011. One day VWAP on date of<br />
exercise was $20.6017.<br />
10 C Page – retired 16 December 2011 so equity transactions are to that date. Transactions<br />
include those that transpired prior to cessation and those that were forfeited on cessation.<br />
Treatment of equity on retirement is in line with treatment of equity on redundancy. LTI<br />
performance rights granted 31 October 2008 were exercised on 14 November 2011. One day<br />
VWAP on date of exercise was $20.8876. Due to cessation, 11,452 LTI deferred shares granted<br />
12 November 2010 were forfeited and processed by Computershare on 20 December 2011.<br />
11 The Disclosed Executives had a proportion of their STI amount deferred as equity. In <strong>2012</strong> D<br />
Hisco received share rights rather than shares due to taxation regulations in New Zealand.<br />
A share right effectively provides a right in the future to acquire a share in ANZ at nil cost<br />
to the employee. Refer to the STI arrangements section for further details of the mandatory<br />
deferral arrangements for the Disclosed Executives and Tables 8 and 9 for details of the<br />
valuation methodology, inputs and fair value.<br />
12 The 2011 LTI grants for Disclosed Executives were delivered as performance rights excluding<br />
for the CRO. Refer to section 6.2.2 LTI Arrangements for further details and Table 8 for details<br />
of the valuation, inputs and fair value.<br />
Disclosed Executives’ Contract Terms<br />
The following sets out details of the contract terms relating to the Disclosed Executives. The contract terms for all Disclosed Executives are<br />
similar, but do on occasion, vary to suit different needs.<br />
Length of contract<br />
Notice periods<br />
Resignation<br />
Termination on<br />
notice by ANZ<br />
Redundancy<br />
Disclosed Executives are on a permanent contract, which is an ongoing employment contract until notice is given<br />
by either party.<br />
In order to terminate the employment arrangements, Disclosed Executives are required to provide the Company<br />
with six months’ written notice. ANZ must provide Disclosed Executives with 12 months’ written notice.<br />
On resignation, unless the Board determines otherwise, all unvested deferred shares, all unvested or vested but<br />
unexercised performance rights, all options and all deferred share rights are forfeited.<br />
ANZ may terminate the Disclosed Executive’s employment by providing 12 months’ written notice or payment<br />
in lieu of the notice period based on fixed remuneration. On termination on notice by ANZ, unless the Board<br />
determines otherwise:<br />
all unvested deferred shares, performance rights, options and deferred share rights are forfeited at the time notice<br />
is given to the Disclosed Executive; and<br />
only performance rights, options and deferred share rights that are vested may be exercised.<br />
If ANZ terminates employment for reasons of redundancy, a severance payment will be made that is equal to<br />
12 months’ fixed remuneration.<br />
All STI deferred shares and STI deferred share rights remain subject to clawback and are released at the original<br />
vesting date. Options, performance rights, LTI deferred shares and LTI deferred share rights are either released in<br />
full or on a pro-rata basis, at the discretion of the Board with regard to the circumstances.<br />
Death or total and<br />
permanent disablement<br />
Termination for<br />
serious misconduct<br />
Statutory Entitlements<br />
Other arrangements<br />
On death or total and permanent disablement all unvested STI deferred shares, all deferred share rights, performance<br />
rights and all options will vest.<br />
ANZ may immediately terminate the Disclosed Executive’s employment at any time in the case of serious misconduct,<br />
and the employee will only be entitled to payment of fixed remuneration up to the date of termination.<br />
On termination without notice by ANZ in the event of serious misconduct any options, performance rights, deferred<br />
shares and deferred share rights still held in trust will be forfeited.<br />
Payment of statutory entitlements of long service leave and annual leave applies in all events of separation.<br />
P Chronican<br />
As Mr Chronican joined ANZ in November 2009 he was not included in the LTI grants made to other Management<br />
Board members in early November 2009. Accordingly, a separate LTI grant was made in December 2009 providing<br />
performance rights on the same terms and conditions as those provided to Management Board for 2009, apart from<br />
the allocation value which varied to reflect the different values at the respective grant dates.<br />
A Thursby<br />
As part of Mr Thursby’s employment arrangement, he was granted three separate tranches of deferred shares to the<br />
value of $1 million per annum, subject to Board approval. The first tranche was granted in September 2007 and vested<br />
in September 2010, the second tranche was granted in August 2008 and vested in August 2011, and the third tranche<br />
was granted in September 2009 and vested in September <strong>2012</strong>.<br />
REMUNERATION REPORT 29